Merck rebuts petition urging SCOTUS to ignore Fosamax appeal

Merck & Co. has been fighting to take its appeal in the years-long Fosamax product liability litigation to the Supreme Court, and if it succeeds, the ruling could affect liability lawsuits across Big Pharma. So when the respondents in the case filed a brief urging SCOTUS to ignore the company's appeal last week, Merck fired back with a strongly worded brief of its own.